Insulet Corp. (PODD)
167.44
-3.95
(-2.30%)
USD |
NASDAQ |
May 05, 16:00
167.44
0.00 (0.00%)
After-Hours: 20:00
Insulet Cash from Investing (Quarterly) : -152.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -591.00M |
| Abbott Laboratories | -20.32B |
| Intuitive Surgical, Inc. | -914.50M |
| Stryker Corp. | -185.00M |
| Tandem Diabetes Care, Inc. | -14.98M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 183.30M |
| Cash from Financing (Quarterly) | -72.50M |
| Free Cash Flow | 349.90M |
| Free Cash Flow Per Share (Quarterly) | 0.4797 |
| Free Cash Flow to Equity (Quarterly) | 63.30M |
| Free Cash Flow to Firm (Quarterly) | 48.12M |
| Free Cash Flow Yield | 2.92% |